Brivaracetam  50mg"'"'''

Brivaracetam 

BVM GOLD is an antiepileptic drug (AED) that is used in the treatment of epilepsy. It belongs to the racetam class of drugs and is chemically related to levetiracetam, another antiepileptic medication. BVM GOLD is marketed under the brand name Briviact. The exact mechanism of action of BVM GOLD is not fully understood. However, like levetiracetam, it is believed to modulate synaptic neurotransmission by binding to synaptic vesicle protein 2A (SV2A) in the brain. This interaction is thought to contribute to the antiepileptic effects of the drug. BVM GOLD is approved for the treatment of partial-onset seizures in adults and adolescents aged 16 years and older with epilepsy. It may be used as monotherapy or as an adjunctive therapy with other antiepileptic medications. The dosage of BVM GOLD varies depending on factors such as the patient's age, weight, and other medications they may be taking. It is typically administered orally as tablets or as an oral solution. Common side effects of BVM GOLD may include dizziness, somnolence (sleepiness), fatigue, headache, and nausea. Serious side effects are rare but can include psychiatric symptoms such as aggression, agitation, and irritability. Patients should report any unusual or severe side effects to their healthcare provider. BVM GOLD can interact with other medications, and it's important for healthcare providers to be aware of all the drugs a patient is taking to avoid potential interactions. For example, it may interact with drugs that affect renal function. Before starting BVM GOLD, healthcare providers should assess patients for a history of psychiatric disorders and monitor them for any signs of psychiatric symptoms during treatment. Additionally, dosage adjustments may be necessary for patients with impaired renal function. For further information please contact: info@sterispharma.com Order Now - https://www.sterisonline.com/product/bvm-gold-50-133543